The direct and indirect cost burden of acute coronary syndrome.

Thomson Reuters, Washington, DC, USA.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine (Impact Factor: 1.8). 01/2011; 53(1):2-7. DOI: 10.1097/JOM.0b013e31820290f4
Source: PubMed

ABSTRACT Quantify the incremental health care costs and workplace absence and short-term disability costs, to payers and employers, of patients hospitalized for acute coronary syndrome (ACS).
Retrospective study using medical insurance claims for the years 2002 to 2007. Patients were aged 18 to 64 years and hospitalized for ACS between January 1, 2003, and December 31, 2006; comparison patients without evidence of coronary artery disease were also selected. The incremental impact of ACS was estimated using weighted regression.
30,200 ACS patients were selected. Incremental annual direct costs of ACS were $40,671 (P < 0.001). For the indirect cost sub-analyses, incremental short-term disability costs of ACS were $999 (P < 0.001) and incremental absence costs were insignificant (P = 0.314) but from a small sample (N = 416).
Patients with ACS impose a substantial direct cost burden on employers and payers and a substantial indirect cost burden on employers. Acute coronary syndrome is more costly to employers and payers than other health conditions that are common among employed persons. Rehospitalizations after the initial hospitalization are common and represent a large portion of the cost.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease (CVD) continues to be a leading cost driver for payers in the United States.1 The American Heart Association estimates that more than 75 million individuals nationwide have some form of CVD. Individuals aged 20 to 45 years are developing CVD at higher rates than ever before.
    American Health and Drug Benefits 09/2011; 4(5):280-8.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Elevated scores on depression symptom questionnaires predict rehospitalization after acute myocardial infarction (AMI). Whether the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, depressive disorders predict rehospitalization after AMI is unknown. Participants (n=766) in an Enhancing Recovery and Coronary Heart Disease ancillary study were classified by diagnostic interview as having no depression, minor depression, or major depression after AMI. Cardiac rehospitalizations were tracked for up to 42 months. Cox proportional hazards regression was used to model the effect of depressive disorder on time to first cardiac rehospitalization, controlling for mortality risk factors. Logistic regression was used to compare the accuracy with which rehospitalization could be predicted by depression diagnosis or by the Beck Depression Inventory (BDI). Secondary analyses examined the effects of depression on the cumulative number of all-cause rehospitalizations, length of stay, and emergency department visits. Compared with patients without depression, patients with either minor or major depression were hospitalized sooner (minor depression adjusted hazard ratio, 2.22; 95% CI, 1.59-3.08; P<0.001; major depression adjusted hazard ratio, 2.54; 95% CI, 1.84-3.53; P<0.001), had more hospitalizations (minor, P<0.001; major, P<0.001) and emergency department visits (minor, P=0.003; major, P<0.001), and spent more days in the hospital (minor, P<0.001; major, P<0.001). The interview and questionnaire methods of assessing depression did not significantly differ in their overall accuracy of predicting rehospitalization. Depressive disorders increase the risk of rehospitalization after AMI. Future work should focus on developing multivariable models to predict risk of rehospitalization after AMI, and depression should be included in these.
    Circulation Cardiovascular Quality and Outcomes 11/2011; 4(6):626-33. DOI:10.1161/CIRCOUTCOMES.111.961896 · 5.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine the short-term disability (STD) and lost work productivity related to laryngeal disorders. A retrospective analysis of a national database of work absence and STD claims was performed. Patients with 12 months of follow-up who had an STD claim specifically linked to a dysphonia diagnosis based on ICD-9 codes were identified during the period of January 1, 2004, to December 31, 2008. Patient age, sex, and diagnosis and the total number of work days absent were determined. Using the mean national hourly wage, productivity losses in terms of lost wages were calculated. Of the 18,466 unique patients with an STD claim, 386 (2.1%) had an STD claim due to a laryngeal disorder. The mean age was 45.9 years (standard deviation, 9.6) with 53.2% male. The mean number of work days absent was 39.2 days (95% confidence interval: 31.9-46.5). Total STD payments in 2008 dollars were $647,269.30 with a mean per person in 12 months of $3,406.68. Total and mean lost wages in 12 months were $843,198.72 and $4,437.89, respectively. Patients with laryngeal cancer had the most days absent and highest total STD payment. Laryngeal disorders lead to work-related disability with STD and productivity losses and represent a significant societal burden. Managing work limitations from laryngeal disorders is an important public health goal.
    The Laryngoscope 07/2012; 122(7):1589-94. DOI:10.1002/lary.23197 · 2.03 Impact Factor
Show more